Institution
UNC Lineberger Comprehensive Cancer Center
Also known as: Lineberger Cancer Center · Lineberger Cancer Research Center · Lineberger Comprehensive Cancer Center · UNC Cancer Center · UNC Comprehensive Cancer Center · University of North Carolina Cancer Center
- 276running trials
- 86closed trials
- 1researcher
- 18,293publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Characterizing Tumor Hypoxia With BOLD-MRI to Predict Y-90 Treatment Response
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent
Not yet recruiting
Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors
Recruiting
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Recruiting
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
Recruiting
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Recruiting
Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies
Recruiting
Recruiting
Recruiting
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
Recruiting
Recruiting
Recruiting
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Recruiting
Recruiting
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Recruiting
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Recruiting
Recruiting
Recruiting
Recruiting
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Recruiting
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Recruiting
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
Showing 50 of 276.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers25 recruiting
- Acute lymphoblastic leukaemia11 recruiting
- Acute myeloid leukaemia9 recruiting
- Chronic lymphocytic leukaemia9 recruiting
- Pancreatic cancer9 recruiting
- Head and neck cancer8 recruiting
- Lung cancer8 recruiting
- Bladder cancer7 recruiting
- Multiple myeloma7 recruiting
- Myelodysplastic syndromes7 recruiting
- Ovarian cancer7 recruiting
- Endometrial cancer6 recruiting
- Follicular lymphoma5 recruiting
- Gastric and oesophageal cancer5 recruiting
- Kidney cancer5 recruiting
- Triple-negative breast cancer5 recruiting
- Colorectal cancer4 recruiting
- Diffuse large B-cell lymphoma4 recruiting
- Mantle cell lymphoma4 recruiting
- Metastatic breast cancer4 recruiting
- Myeloproliferative neoplasms4 recruiting
- Prostate cancer4 recruiting
- Sarcoma4 recruiting
- Amyloidosis3 recruiting
- Cervical cancer3 recruiting
- Chronic myeloid leukaemia3 recruiting
- Down syndrome3 recruiting
- Hodgkin lymphoma3 recruiting
- Neuroblastoma3 recruiting
- Obesity3 recruiting
- Barrett's oesophagus2 recruiting
- Burkitt lymphoma2 recruiting
- Glioblastoma2 recruiting
- Liver and biliary tract cancer2 recruiting
- Melanoma2 recruiting
- Neuroendocrine tumours2 recruiting
- Aplastic anaemia1 recruiting
- Hearing loss1 recruiting
- Neurofibromatosis type 11 recruiting
- Testicular cancer1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Withdrawn
Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation
Terminated
Withdrawn
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
Terminated
Completed
Terminated
Completed
Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors
Completed
Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
Terminated
Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Completed
Terminated
Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML
Withdrawn
Completed
Completed
Completed
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
Completed
Completed
Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer
Completed
GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses
Completed
Completed
Completed
Completed
Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
Completed
Completed
Completed
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Completed
Recruiting
Completed
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
Completed
Terminated
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML
Completed
Completed
Completed
Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin
Completed
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Showing 50 of 86.
Registry name variants (21)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27599
291 trials
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
Chapel Hill, North Carolina 27599
26 trials
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27599
21 trials
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27599
7 trials
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27514
6 trials
Lineberger Comprehensive Cancer Center at University of North Carolina
Chapel Hill, North Carolina 27599
4 trials
Lineberger Comprehensive Cancer Center, University of North Carolina
Chapel Hill, North Carolina 27599
2 trials
UNC Lineberger Comprehensive Cancer Center / University of North Carolina
Chapel Hill, North Carolina 27599
2 trials
Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27599
1 trial
The UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27514
1 trial
UNC Cancer Center
Chapel Hill, North Carolina 27514
1 trial
UNC Lineberger Comprehensive Cancer Center
Durham, North Carolina 27705
1 trial
NCT06365060Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Contact: Kendall Conder
UNC Lineberger Comprehensive Cancer Center (Site 3250)
Chapel Hill, North Carolina 27514
1 trial
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center (Adults and Pediatrics)
Chapel Hill, North Carolina 27599
1 trial
University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27599
1 trial
University of North Carolina Brain Tumor Program - UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27599
1 trial
University of North Carolina - Chapel Hill Comprehensive Cancer Center
Chapel Hill, North Carolina 27599
1 trial
University of North Carolina Lineberger Cancer Center
Chapel Hill, North Carolina 27599
1 trial
University of North Carolina, Lineberger Cancer Ctr
Chapel Hill, North Carolina 27599
1 trial
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27599
1 trial
University of North Carolina (UNC) - Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27514
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Triple-negative breast cancer31 works · 11 trials
- Pancreatic cancer29 works · 15 trials
- Metastatic breast cancer24 works · 17 trials
- Endometrial cancer16 works · 16 trials
- Myelodysplastic syndromes8 works · 15 trials
Institution data: ROR 043ehm030 (CC0-1.0)Updated 15 Nov 2026